TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

Clinical trial NCT04915482 · UNKNOWN

Trial details

NCT number: NCT04915482
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Immune Thrombocytopenia (ITP)Autoantibodies Evan Syndrome Connective Tissue Diseases

Start date: 2021-06-06
Primary completion: 2025-01-31
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.